USA v. Chan
Case Number:
1:16-cr-10268
Court:
Nature of Suit:
Firms
Companies
Sectors & Industries:
-
June 27, 2018
Insider Trading Suspect's Son Shouldn't Testify, Judge Says
Federal prosecutors cannot force the young-adult son of an insider trading suspect to testify against his father, the presiding judge ruled Wednesday on the third day of a securities fraud trial in Boston.
-
June 26, 2018
Ex-Akebia Statistician Jailed For Speaking To Trial Witness
Shortly after his lawyer extolled his intelligence to a Massachusetts federal jury Tuesday morning, a former biostatistician at Akebia Therapeutics Inc. was ordered to spend a night in the custody of the U.S. Marshals Service after defying a federal judge's order by speaking to a witness who testified on the insider trading trial's opening day.
-
June 22, 2018
Feds Can Use 'Material, Nonpublic Info' At Insider Trading Trial
Two biostatisticians charged with insider trading cannot preclude prosecutors from saying "material, nonpublic information" at their imminent securities fraud trial in Boston, a federal judge ruled on Friday.
-
June 19, 2018
Former Akebia, Merrimack Buddies Face Insider Trading Trial
Two former biostatistician friends at Akebia Therapeutics Inc. and Merrimack Pharmaceuticals Inc. will face securities fraud charges for allegedly cashing in on nonpublic drug trial information, a federal judge in Massachusetts said Tuesday.
-
May 30, 2018
Jury Must Hear Wife's Role At Insider Trades Trial, Feds Say
Federal prosecutors petitioned a judge Wednesday to ensure that, if the wife of a former director at Akebia Therapeutics Inc. refuses to testify against her husband at his insider-trading trial in Boston next month, the government can call an FBI agent to relay statements she has made about the alleged scheme.
-
November 16, 2017
Pharma Trading Suspects Denied Bid To Trim Suit
A Massachusetts federal judge on Thursday refused to trim a lawsuit alleging insider trading by two former employees of Akebia Therapeutics Inc. and Merrimack Pharmaceuticals Inc.
-
November 03, 2017
Feds Say Pharma Trading Suspects Can't Get Early Win
Prosecutors asked a Massachusetts federal court Friday to shoot down a request by two pharmaceutical employees to dismiss the insider trading charges against them, saying they had tried to sneak a challenge to the government's evidence into a procedural phase of the case.
-
October 24, 2017
Pharma Insider Trading Suspects Deny Using Nonpublic Info
Two former Akebia Therapeutics Inc. and Merrimack Pharmaceuticals Inc. employees on Monday asked a Massachusetts federal court to gut insider trading allegations against them, claiming neither traded securities based on nonpublic information that could reasonably affect Akebia stock.
-
October 12, 2017
'Dr. Jekyll' Pharma Insider Trading Suspect Released Again
A Boston judge decided Thursday to release a former pharmaceutical executive accused of insider trading while he awaits trial despite the court's concerns that the defendant's "Dr. Jekyll and Mr. Hyde" tendencies might reappear.
-
September 25, 2017
Judge Rips Insider Trading Suspect's 'Arrogance'
A Massachusetts federal magistrate judge on Monday said he would order an evaluation for a former pharmaceutical company insider trading suspect who was jailed for a series of increasingly bizarre stunts.
- ← Previous
- 1
- 2
- 3
- Next →